178 related articles for article (PubMed ID: 30684199)
1. Factors Affecting Adherence in a Pragmatic Trial of Annual Fecal Immunochemical Testing for Colorectal Cancer.
Nielson CM; Vollmer WM; Petrik AF; Keast EM; Green BB; Coronado GD
J Gen Intern Med; 2019 Jun; 34(6):978-985. PubMed ID: 30684199
[TBL] [Abstract][Full Text] [Related]
2. Effect of Reminding Patients to Complete Fecal Immunochemical Testing: A Comparative Effectiveness Study of Automated and Live Approaches.
Coronado GD; Rivelli JS; Fuoco MJ; Vollmer WM; Petrik AF; Keast E; Barker S; Topalanchik E; Jimenez R
J Gen Intern Med; 2018 Jan; 33(1):72-78. PubMed ID: 29019046
[TBL] [Abstract][Full Text] [Related]
3. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial.
Gupta S; Halm EA; Rockey DC; Hammons M; Koch M; Carter E; Valdez L; Tong L; Ahn C; Kashner M; Argenbright K; Tiro J; Geng Z; Pruitt S; Skinner CS
JAMA Intern Med; 2013 Oct; 173(18):1725-32. PubMed ID: 23921906
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of a Mailed Colorectal Cancer Screening Outreach Program in Community Health Clinics: The STOP CRC Cluster Randomized Clinical Trial.
Coronado GD; Petrik AF; Vollmer WM; Taplin SH; Keast EM; Fields S; Green BB
JAMA Intern Med; 2018 Sep; 178(9):1174-1181. PubMed ID: 30083752
[TBL] [Abstract][Full Text] [Related]
5. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
[TBL] [Abstract][Full Text] [Related]
6. Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial.
Baker DW; Brown T; Buchanan DR; Weil J; Balsley K; Ranalli L; Lee JY; Cameron KA; Ferreira MR; Stephens Q; Goldman SN; Rademaker A; Wolf MS
JAMA Intern Med; 2014 Aug; 174(8):1235-41. PubMed ID: 24934845
[TBL] [Abstract][Full Text] [Related]
7. Strategies and Opportunities to STOP Colon Cancer in Priority Populations: design of a cluster-randomized pragmatic trial.
Coronado GD; Vollmer WM; Petrik A; Taplin SH; Burdick TE; Meenan RT; Green BB
Contemp Clin Trials; 2014 Jul; 38(2):344-9. PubMed ID: 24937017
[TBL] [Abstract][Full Text] [Related]
8. Improving Fecal Immunochemical Testing Rates for Colon Cancer Screening in the Outpatient Setting.
Hussain W; Aurand W; Onuorah N; Krstevski G; Markert R; Springer K; Agrawal S
South Med J; 2021 Feb; 114(2):77-80. PubMed ID: 33537787
[TBL] [Abstract][Full Text] [Related]
9. Moderators of the effectiveness of an intervention to increase colorectal cancer screening through mailed fecal immunochemical test kits: results from a pragmatic randomized trial.
O'Connor EA; Vollmer WM; Petrik AF; Green BB; Coronado GD
Trials; 2020 Jan; 21(1):91. PubMed ID: 31941527
[TBL] [Abstract][Full Text] [Related]
10. Barriers and Facilitators of Colorectal Cancer Screening in a Federally Qualified Health Center (FQHC).
Ylitalo KR; Camp BG; Umstattd Meyer MR; Barron LA; Benavidez G; Hess B; Laschober R; Griggs JO
J Am Board Fam Med; 2019; 32(2):180-190. PubMed ID: 30850454
[TBL] [Abstract][Full Text] [Related]
11. Uptake of colorectal cancer screening after mailed fecal immunochemical test (FIT) outreach in a newly eligible 45-49-year-old community health center population.
O'Leary MC; Reuland DS; Correa SY; Moore AA; Malo TL; Tan X; Rohweder CL; Wheeler SB; Brenner AT
Cancer Causes Control; 2023 Dec; 34(Suppl 1):125-133. PubMed ID: 37300632
[TBL] [Abstract][Full Text] [Related]
12. Two-year follow-up of the effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers.
Baker DW; Brown T; Goldman SN; Liss DT; Kollar S; Balsley K; Lee JY; Buchanan DR
Cancer Causes Control; 2015 Nov; 26(11):1685-90. PubMed ID: 26337733
[TBL] [Abstract][Full Text] [Related]
13. "Finding the Right FIT": Rural Patient Preferences for Fecal Immunochemical Test (FIT) Characteristics.
Pham R; Cross S; Fernandez B; Corson K; Dillon K; Yackley C; Davis MM
J Am Board Fam Med; 2017; 30(5):632-644. PubMed ID: 28923816
[TBL] [Abstract][Full Text] [Related]
14. Development of a multivariable prediction model to identify patients unlikely to complete a colonoscopy following an abnormal FIT test in community clinics.
Petrik AF; Keast E; Johnson ES; Smith DH; Coronado GD
BMC Health Serv Res; 2020 Nov; 20(1):1028. PubMed ID: 33172444
[TBL] [Abstract][Full Text] [Related]
15. Clinic Factors Associated With Mailed Fecal Immunochemical Test (FIT) Completion: The Difference-Making Role of Support Staff.
Davis MM; Schneider JL; Petrik AF; Miech EJ; Younger B; Escaron AL; Rivelli JS; Thompson JH; Nyongesa D; Coronado GD
Ann Fam Med; 2022; 20(2):123-129. PubMed ID: 35346927
[TBL] [Abstract][Full Text] [Related]
16. Colonoscopy Following an Abnormal Fecal Test Result from an Annual Colorectal Cancer Screening Program in a Federally Qualified Health Center.
Escaron AL; Garcia J; Petrik AF; Ruiz E; Nyongesa DB; Thompson JH; Coronado GD
J Prim Care Community Health; 2022; 13():21501319221138423. PubMed ID: 36448466
[TBL] [Abstract][Full Text] [Related]
17. Patient-Reported Barriers to Completing a Diagnostic Colonoscopy Following Abnormal Fecal Immunochemical Test Among Uninsured Patients.
Jetelina KK; Yudkin JS; Miller S; Berry E; Lieberman A; Gupta S; Balasubramanian BA
J Gen Intern Med; 2019 Sep; 34(9):1730-1736. PubMed ID: 31228053
[TBL] [Abstract][Full Text] [Related]
18. Effect of Patient Portal Messaging Before Mailing Fecal Immunochemical Test Kit on Colorectal Cancer Screening Rates: A Randomized Clinical Trial.
Goshgarian G; Sorourdi C; May FP; Vangala S; Meshkat S; Roh L; Han MA; Croymans DM
JAMA Netw Open; 2022 Feb; 5(2):e2146863. PubMed ID: 35119462
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and cost of multilayered colorectal cancer screening promotion interventions at federally qualified health centers in Washington State.
Kemper KE; Glaze BL; Eastman CL; Waldron RC; Hoover S; Flagg T; Tangka FKL; Subramanian S
Cancer; 2018 Nov; 124(21):4121-4129. PubMed ID: 30359468
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
